112 related articles for article (PubMed ID: 16798784)
1. Live viral vaccines in a DiGeorge syndrome patient.
Waters V; Peterson KS; LaRussa P
Arch Dis Child; 2007 Jun; 92(6):519-20. PubMed ID: 16798784
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of measles-mumps-rubella vaccine in children with congenital immunodeficiency (DiGeorge syndrome).
Azzari C; Gambineri E; Resti M; Moriondo M; Betti L; Saldias LR; G Gelli AM; Vierucci A
Vaccine; 2005 Feb; 23(14):1668-71. PubMed ID: 15705470
[TBL] [Abstract][Full Text] [Related]
3. Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Perez EE; Bokszczanin A; McDonald-McGinn D; Zackai EH; Sullivan KE
Pediatrics; 2003 Oct; 112(4):e325. PubMed ID: 14523220
[TBL] [Abstract][Full Text] [Related]
4. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
[TBL] [Abstract][Full Text] [Related]
5. [Live Vaccine in Children with DiGeorge/22q11.2 Deletion Syndrome].
Miranda M; Martins AT; Carvalho S; Serra-Caetano A; Esteves I; Marques JG
Acta Med Port; 2019 Aug; 32(7-8):514-519. PubMed ID: 31445531
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of measles, mumps, and rubella vaccine in patients with DiGeorge syndrome.
Al-Sukaiti N; Reid B; Lavi S; Al-Zaharani D; Atkinson A; Roifman CM; Grunebaum E
J Allergy Clin Immunol; 2010 Oct; 126(4):868-9. PubMed ID: 20810153
[No Abstract] [Full Text] [Related]
7. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity.
Moylett EH; Wasan AN; Noroski LM; Shearer WT
Clin Immunol; 2004 Jul; 112(1):106-12. PubMed ID: 15207787
[TBL] [Abstract][Full Text] [Related]
8. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS.
Pediatrics; 1999 May; 103(5 Pt 1):1057-60. PubMed ID: 10224192
[TBL] [Abstract][Full Text] [Related]
9. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella.
Nascimento Silva JR; Camacho LA; Siqueira MM; Freire Mde S; Castro YP; Maia Mde L; Yamamura AM; Martins RM; Leal Mde L;
Vaccine; 2011 Aug; 29(37):6327-34. PubMed ID: 21640779
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
[TBL] [Abstract][Full Text] [Related]
12. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps.
Smorodintsev AA; Nasibov MN; Jakovleva NV
Bull World Health Organ; 1970; 42(2):283-9. PubMed ID: 5310140
[TBL] [Abstract][Full Text] [Related]
13. Live viral vaccines in patients with DiGeorge syndrome.
Sullivan KE
Clin Immunol; 2004 Oct; 113(1):3. PubMed ID: 15380522
[No Abstract] [Full Text] [Related]
14. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
15. Combined vaccine against measles, mumps, rubella, and varicella.
Brunell PA; Novelli VM; Lipton SV; Pollock B
Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
[TBL] [Abstract][Full Text] [Related]
16. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey.
McLaughlin M; Thomas P; Onorato I; Rubinstein A; Oleske J; Nicholas S; Krasinski K; Guigli P; Orenstein W
Pediatrics; 1988 Aug; 82(2):229-33. PubMed ID: 3399296
[TBL] [Abstract][Full Text] [Related]
17. 22q11.2 deletion syndrome with life-threatening adenovirus infection.
Ip W; Zhan H; Gilmour KC; Davies EG; Qasim W
J Pediatr; 2013 Sep; 163(3):908-10. PubMed ID: 23660376
[TBL] [Abstract][Full Text] [Related]
18. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
19. [Invasive infection in an immunosuppressed patient].
de Miguel-MartÃnez I; de Malet Pintos-Fonseca A; del Rosario-Quintana C; Ojeda-Vargas M
Enferm Infecc Microbiol Clin; 2011; 29(7):545-6. PubMed ID: 21342733
[No Abstract] [Full Text] [Related]
20. [A special immunization clinic tailors vaccinations].
Aronsson B; Blennow M
Lakartidningen; 2008 May 28-Jun 3; 105(22):1675-9. PubMed ID: 18590010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
